Tweet
Washington Regional provides 600+ monoclonal antibody treatments for COVID-19 patients
by: Megan Wilson
Posted: Feb 22, 2021 / 04:11 PM CST / Updated: Feb 22, 2021 / 04:11 PM CST
FAYETTEVILLE, Ark. (news release) – Washington Regional has provided more than 620 monoclonal antibody treatments to COVID-positive patients since November, helping reduce hospitalizations due to serious illness.
Antibody treatment, which is delivered through an infusion, neutralizes the COVID-19 virus by preventing disease progression.
...
Monoclonal antibody treatment is most effective in the early stage of COVID-19 infection and is approved for COVID-positive patients who are 12 years of age or older, weigh at least 88 pounds, and are at high risk of severe complications from COVID-19. That includes patients age 65 and older and people with certain chronic health conditions. Patients using supplemental oxygen may receive the infusion if their oxygen supplementation requirements have not increased...
Comment